Key Information: Advanced Medical Solutions Group plc
This document outlines critical information regarding the recent public dealing disclosure by an exempt principal trader with Intermediary status, acting in a client-serving capacity.
Understanding the Disclosure
The details provided are in compliance with Rule 8.5 of the Takeover Code, ensuring transparency in the dealings concerning Advanced Medical Solutions Group plc shares. Keeping track of these disclosures is crucial for investors who want to understand the trading behavior surrounding the company.
Trader Information
The exempt principal trader making this disclosure is Investec Bank plc. They hold a significant role as the financial advisor, nominated advisor (NOMAD), and corporate broker to Advanced Medical Solutions Group plc.
Relevant Securities
This disclosure pertains to the relevant securities of Advanced Medical Solutions Group plc, ensuring all dealings by the exempt principal trader are accurately reported.
Dealings Summary
The dealings highlighted within this disclosure primarily consist of purchases and sales, detailing ordinary shares of Advanced Medical Solutions Group plc. Key information includes total securities traded, highest and lowest prices per unit, reflecting the market's response and trading activity during the period.
Purchases and Sales Details
According to the records, a total of 40,000 ordinary shares were both purchased and sold at a price of 233 per unit. This reflects a stable trading environment for the company, with the price remaining consistent across the transactions.
Derivative Transactions
In addition to the purchase and sale of ordinary shares, the disclosure includes information regarding cash-settled and stock-settled derivative transactions. However, it notes that for these categories, no transactions occurred during this period.
Other Important Information
Within the document, there's a section dedicated to any indemnity arrangements or understandings that may influence trading. In this case, it states that there are no such agreements in place, ensuring a clear and unbiased trading operation.
Investec’s Role
Investec’s connection with Advanced Medical Solutions Group plc underscores their influence in these transactions as advisors. They play a pivotal role in guiding the company through its financial dealings and ensuring compliance with trading regulations.
Disclosure Date and Contact
The date of this disclosure is noted as the 2nd of April 2025. For further inquiries regarding this disclosure, contact is handled by Abhishek Gawde, available at the phone number +91 9923757332. This ensures stakeholders can reach out for clarifications if necessary.
Frequently Asked Questions
What is the significance of the party names in the disclosure?
The names involved, such as Investec Bank plc and Advanced Medical Solutions Group plc, indicate key players in the transactions, helping investors understand who is responsible for trading activities.
What does the Rule 8.5 entail for traders?
Rule 8.5 mandates that exempt principal traders disclose certain transactions to promote transparency in securities dealings, aiding stakeholders in evaluating market movements.
How do price per unit figures affect trading decisions?
Price per unit figures provide insight into trading patterns, allowing investors to make informed decisions based on market performance and share value fluctuations.
Who can be contacted for more information about the disclosures?
Investors can contact Abhishek Gawde for additional information regarding the disclosures, ensuring they can clarify any uncertainties they have.
Why is it essential to monitor such disclosures?
Monitoring these disclosures is essential as they provide valuable insights into the trading behaviors surrounding a company, which can impact stock performance and investment strategies.
